Nogest (Nomegestrol Acetate)

Nomegestrol Acetate, the active ingredient in Nogest, is a progestin presented as an oral formulation for systemic use. It is employed in hormonal contraceptive regimens and hormone replacement therapy to regulate menstrual cycles and provide estrogen‑free contraception in women of reproductive age. It is indicated for women seeking reliable contraception without estrogen and for those requiring menopausal symptom management.

GNH USA supplies Nogest as a licensed, GDP‑compliant international pharmaceutical product serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable supply chains for global healthcare providers.

Nomegestrol acetate, a synthetic progestin, is employed in hormonal pathways related to contraception and estrogen‑free hormone replacement. - Contraception: provides reliable estrogen‑free birth control as part of combined oral contraceptive regimens. - Hormone replacement therapy: supplies progestogenic activity to counterbalance estrogen in menopausal therapy. - Menstrual cycle regulation: helps normalize cycle length and reduce irregular bleeding in women with hormonal imbalance.

Nomegestrol acetate may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: occasional stomach upset or queasiness. - Headache: mild to moderate tension‑type headaches. - Breast tenderness: transient discomfort or swelling of breast tissue. - Irregular menstrual bleeding: spotting or changes in flow pattern.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Liver enzyme elevation: abnormal liver function tests indicating hepatic stress.

When prescribing Nogest, clinicians should consider several precautionary measures to ensure patient safety. - Assess thrombotic risk: evaluate history of blood clots before initiating therapy. - Evaluate liver function: perform baseline hepatic tests and monitor periodically. - Monitor blood pressure: watch for hypertension during treatment. - Counsel on smoking: advise patients to avoid smoking, especially if over 35 years old. - Review concomitant medications: check for drugs that may interact with progestins. - Store at ambient temperature: keep tablets in original packaging, protect from moisture and heat.

Nomegestrol acetate can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin): may reduce contraceptive efficacy. - Anticoagulants (e.g., warfarin): potential alteration of clotting parameters. - Potent CYP3A4 inhibitors (e.g., ketoconazole): may increase progestin levels.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): may affect bleeding patterns. - Antihypertensive agents: additive blood pressure‑lowering effect. - St. John’s wort: herbal inducer that could diminish contraceptive effectiveness.